[
    {
        "source": "Upadacitinib",
        "target": "Inflammatory Bowel Disease",
        "relationship": "treats",
        "description": "Upadacitinib is used for the treatment of inflammatory bowel disease (IBD)."
    },
    {
        "source": "Risankizumab",
        "target": "Inflammatory Bowel Disease",
        "relationship": "treats",
        "description": "Risankizumab is used for the treatment of inflammatory bowel disease (IBD)."
    },
    {
        "source": "Upadacitinib",
        "target": "Crohn's Disease",
        "relationship": "treats",
        "description": "Upadacitinib is administered to Crohn's disease patients who inadequately respond to anti-TNF-\u03b1 treatment."
    },
    {
        "source": "Risankizumab",
        "target": "Crohn's Disease",
        "relationship": "treats",
        "description": "Risankizumab is administered to Crohn's disease patients who inadequately respond to anti-TNF-\u03b1 treatment."
    }
]